Position
Squarepoint Ops LLC in Zenas BioPharma, Inc.
Back to the book · All holders of ZBIO
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$260.5K$36.31 → $19.55
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 15.5K | $564.3K | — | — | — | 0.0% |
| Q1 2026 | 42.9K | $838.2K | $19.55 | −$260.5K | $534.4K | 0.0% |